SELLAS Life Sciences Group, Inc. (SLS)
11.54
-1.94
(-14.42%)
USD |
NASDAQ |
Sep 11, 16:00
11.56
+0.02
(+0.13%)
After-Hours: 20:00
SELLAS Life Sciences Group Price to Book Value : 16.93 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 16.93 |
| September 10, 2026 | 19.79 |
| September 09, 2026 | 20.46 |
| September 08, 2026 | 20.48 |
| September 04, 2026 | 20.33 |
| September 03, 2026 | 20.10 |
| September 02, 2026 | 20.77 |
| September 01, 2026 | 19.39 |
| August 31, 2026 | 19.57 |
| August 28, 2026 | 19.38 |
| August 27, 2026 | 22.31 |
| August 26, 2026 | 20.14 |
| August 25, 2026 | 20.67 |
| August 24, 2026 | 21.01 |
| August 21, 2026 | 22.68 |
| August 20, 2026 | 19.66 |
| August 19, 2026 | 20.32 |
| August 18, 2026 | 19.22 |
| August 17, 2026 | 19.07 |
| August 14, 2026 | 18.75 |
| August 13, 2026 | 18.13 |
| August 12, 2026 | 17.26 |
| August 11, 2026 | 16.21 |
| August 10, 2026 | 16.19 |
| August 07, 2026 | 17.62 |
| Date | Value |
|---|---|
| August 06, 2026 | 17.16 |
| August 05, 2026 | 17.40 |
| August 04, 2026 | 17.32 |
| August 03, 2026 | 16.46 |
| July 31, 2026 | 14.68 |
| July 30, 2026 | 15.09 |
| July 29, 2026 | 14.82 |
| July 28, 2026 | 14.80 |
| July 27, 2026 | 15.89 |
| July 24, 2026 | 16.60 |
| July 23, 2026 | 18.10 |
| July 22, 2026 | 17.72 |
| July 21, 2026 | 18.92 |
| July 20, 2026 | 18.30 |
| July 17, 2026 | 19.35 |
| July 16, 2026 | 17.24 |
| July 15, 2026 | 18.76 |
| July 14, 2026 | 19.64 |
| July 13, 2026 | 18.51 |
| July 10, 2026 | 18.72 |
| July 09, 2026 | 19.82 |
| July 08, 2026 | 20.18 |
| July 07, 2026 | 19.80 |
| July 06, 2026 | 20.45 |
| July 02, 2026 | 21.97 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Lite Strategy, Inc. | 0.6866 |
| AbbVie, Inc. | -- |
| Marker Therapeutics, Inc. | 1.576 |
| TG Therapeutics, Inc. | 13.66 |
| Rezolute, Inc. | 3.478 |
Price to Book Value Related Metrics
| Price | 11.54 |
| Earnings Yield | -1.84% |
| Market Cap | 2.331B |